• Expansion to create 50 new high-skilled jobs in AI and reinforce Sanofi's long-term commitment to Ontario
  • Invest Ontario Fund to contribute a conditional grant of up to $5 million
  • Partnership with the Province of Ontario and Toronto's strong AI talent pool key drivers in site selection

TORONTO, May 4, 2026 /CNW/ - Sanofi, an R&D-driven, AI-powered biopharma company and Canada's largest biopharma manufacturer, is expanding its global Artificial Intelligence (AI) Centre of Excellence in Toronto, deepening its investment in Ontario and growing AI talent to develop and manufacture life-changing medicines and vaccines faster than ever before.

The $294 million expansion will create 50 new high-skilled jobs in artificial intelligence and machine learning, building on the more than 150 roles created in just four years since establishing the AI Centre of Excellence (COE) in 2022 in downtown Toronto. These new roles will lead the design and deployment of advanced AI tools used throughout Sanofi's global research, manufacturing and business operations, accelerating the delivery of breakthrough medicines and vaccines to patients worldwide.

The expansion will be supported by a conditional grant of up to $5 million from the Invest Ontario Fund, which recognizes Sanofi's sustainable, long-term commitment to Ontario's innovation ecosystem, and reinforces the province's position as a global leader in AI-powered healthcare innovation.